Hospitalizations and deaths within 60 days of fluoropyrimidine chemotherapy initiation among Medicare patients with colorectal cancer.

被引：0
|
作者：
Brooks, Gabriel [1 ]
Cronin, Angel [1 ]
Schrag, Deborah [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.3603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3603
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Risk of cardiovascular disease among different fluoropyrimidine-based chemotherapy regimens as adjuvant treatment for resected colorectal cancer
    Huang, Wen-Kuan
    Ho, Wei-Pang
    Hsu, Hung-Chih
    Chang, Shu-Hao
    Chen, Dong-Yi
    Chou, Wen-Chi
    Chang, Pei-Hung
    Chen, Jen-Shi
    Yang, Tsai-Sheng
    See, Lai-Chu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [42] Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients
    Mo, Xianwei
    Huang, Xiaoliang
    Feng, Yan
    Wei, Chunyin
    Liu, Haizhou
    Ru, Haiming
    Qin, Haiquan
    Lai, Hao
    Wu, Guo
    Xie, Weishun
    Jeen, Franco
    Lin, Yuan
    Liu, Jungang
    Tang, Weizhong
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [43] Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy
    Lee, Dae-Won
    Han, Sae-Won
    Cha, Yongjun
    Bae, Jeong Mo
    Kim, Hwang-Phill
    Lyu, Jaemyun
    Han, Hyojun
    Kim, Hyoki
    Jang, Hoon
    Bang, Duhee
    Won, Jae-Kyung
    Jeong, Seung-Yong
    Park, Kyu Joo
    Kang, Gyeong Hoon
    Kim, Tae-You
    BMC CANCER, 2019, 19 (1)
  • [44] HOSPITALIZATIONS AMONG PATIENTS WITH BOTH COLORECTAL CANCER AND TYPE II DIABETES MELLITUS TREATED WITH METFORMIN VS. SULFONYLUREAS: A SEER-MEDICARE ANALYSIS
    Rane, A.
    Reddy, S.
    Kaliki, S.
    Kaler, N.
    Dungrani, R. K.
    Patel, N.
    Murimi, I. B.
    VALUE IN HEALTH, 2023, 26 (06) : S383 - S383
  • [45] Cost implications of potentially avoidable hospitalizations among Oncology Care Model patients with prostate cancer.
    Smith, William H.
    Parikh, Anish B.
    Li, Lihua
    Sanderson, Mark
    Liu, Mark
    Mazumdar, Madhu
    Isola, Luis M.
    Dharmarajan, Kavita Vyas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [46] Outcomes of Irinotecan-Based Chemotherapy Regimens in Elderly Medicare Patients With Metastatic Colorectal Cancer
    Obeidat, Nour A.
    Pradel, Francoise G.
    Zuckerman, Ilene H.
    DeLisle, Sylvain
    Mullins, C. Daniel
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2009, 7 (06): : 343 - 354
  • [47] Inflammatory cytokines and toxic effects of oxaliplatin-based chemotherapy in patients with colorectal cancer.
    Wang, X. S.
    Cleeland, C. S.
    Johnson, V. E.
    Reuben, J. M.
    Fogelman, D. R.
    Malekifar, M.
    Liao, K. E.
    Liu, P.
    Cohen, E. N.
    Gilmore, K. R.
    Eng, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] The cost of hospitalization secondary to severe chemotherapy induced diarrhea (CID) in patients with colorectal cancer.
    Shah, S
    Maroun, J
    Dranitsaris, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 546S - 546S
  • [49] Adherence to oral chemotherapy among colorectal cancer patients: A longitudinal study
    Chen, Yilin
    Wu, Xiaodan
    Xian, Xuemei
    Zhang, Yiheng
    Gong, Ni
    Qin, Huiying
    Zhang, Meifen
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2020, 48
  • [50] Hospice utilization among Medicare managed care and fee-for-service patients dying with cancer.
    Mccarthy, EP
    Burns, RB
    Davis, RB
    Ngo-Metzger, Q
    Phillips, RS
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 180 - 180
12345